GlycoNex Announces First Patient Dosed in Phase 3 Clinical Trial for Denosumab Biosimilar
GlycoNex developing denosumab biosimilar, SPD8, for the treatment of osteoporosis NEW TAIPEI CITY, Taiwan, Dec. 17, 2024 /PRNewswire/ — GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunothera
QuickLogic Announces Appointment of Andy Jaros as Vice President of IP Sales
SAN JOSE, Calif., Dec. 17, 2024 /PRNewswire/ — QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP, ruggedized FPGAs, and endpoint AI solutions, today announced the appointment of Andy Jaros as Vice President of IP Sales, effective immediately. Andy will repor
Mandalay Resources Announces 2025 Outlook and Guidance for Gold and Antimony Production
TORONTO, Dec. 17, 2024 /PRNewswire/ — Mandalay Resources Corporation (“Mandalay” or “the Company”) (TSX: MND) (OTCQB: MNDJF) is pleased to provide its production and cost guidance for 2025, which reflects the Company’s continued commitment to operational excellenc
HYZON RECEIVES ORDER FOR REFUSE COLLECTION AND CLASS 8 200KW FUEL CELL ELECTRIC TRUCKS FROM SOUTH SAN FRANCISCO SCAVENGER COMPANY
Order Follows Successful Trials and is the Hyzon’s Second Fuel Cell Refuse Vehicle Order BOLINGBROOK, Ill., Dec. 17, 2024 /PRNewswire/ — Hyzon (NASDAQ: HYZN) (Hyzon or the Company), a U.S.-based, high-performance, hydrogen fuel cell system manufacturer and technology developer focused on
China Matters’ Feature: Adeh DeSandies: I Want My Own China Story
GUANGZHOU, China, Dec. 17, 2024 /PRNewswire/ — This episode of A Learning Journey delves into the extraordinary life of Ade, a Stanford University graduate and global entrepreneur whose story weaves together cultural heritage, technological innovation, and an enduring spirit of connection. Ad
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection a
Hoyer advances its growth strategy with NowiTek acquisition
HADSTEN, Denmark, Dec. 17, 2024 /PRNewswire/ — Hoyer, a global leader in energy-efficient motor solutions, has taken a strategic step forward with its acquisition of NowiTek, an automation solutions developer specialising in scalable SCADA platforms and PLC-programming. The move reinforces Hoy
Marine Battery Market worth $1,506.0 million by 2030 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Dec. 17, 2024 /PRNewswire/ — The Marine Battery Market is estimated to be USD 882.3 million in 2024 and is projected to reach USD 1,506.0 million by 2030 at a CAGR of 9.3% from 2024 to 2030 according to a new report by MarketsandMarkets™. Marine battery manufacturers focu
Caris Life Sciences Appoints Dr. James Hamrick as Chairman of the Caris Precision Oncology Alliance
IRVING, Texas, Dec. 17, 2024 /PRNewswire/ — Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced James Hamrick, MD, MPH, has been appointed Chairman of the Caris Precision Oncology Alliance™ (Caris POA). As chairman, Dr.
Princess Cruises Introduces 24/7 Dine Line to Expand Reservations Access and Enhance Cruise Experience
1-833-805-DINE Offers Round-the-Clock Access for Dining Reservations, Package Purchases and More FT. LAUDERDALE, Fla., Dec. 17, 2024 /PRNewswire/ — Princess Cruises has launched the Dine Line (1-833-805-DINE), a new 24/7 service designed to make access to dining reservations aboard the Love Bo
